Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

TOT Biopharm

Biotech & Life Sciences · China · Founded 2009 · IPO 2019 Thoroughbred

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$435M
Market cap · Apr/2026
Revenue
$151M
Latest reported FY

Investors

7 investors on TOT Biopharm's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 1 investor entered at this stage
Chengwei Capital
Series B+ 6 investors entered at this stage
99Fund
GoldTech Capital
Cathay Capital
Yuanta Financial Holdings Group
Center Ventures
China Universal Asset Management

Global footprint

Where TOT Biopharm has talent and traffic

Web traffic by country
120 monthly visits
across markets
🇳🇱 Netherlands83.3%
Top 1 markets shown

See TOT Biopharm on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo